Citation:Soni A, Sampliner RE, Sonnenberg A 2000

From Clinical Guidelines Wiki

Citation


Soni A, Sampliner RE, Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol 2000 Aug;95(8):2086-93 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/10950062.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Is surveillance cost-effective for follow-up of patients with BO?Dr Louisa Gordoncompleted
For which populations is screening for BO cost-effective?Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhilcompleted

Compare quality appraisals for each clinical question

Cited by

  1. For which populations is screening for BO cost-effective?